
As international standards like IEC 62304 become more stringent, pharmaceutical firms must implement rigorous inventory control for every algorithmic tool in their inventory. This directive reflects a broader transformation within the industry, where the “survival of the fittest” is no longer just a biological metaphor but a technological reality. Scientists today find themselves at a crossroads, navigating a dense forest










